UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): June 6, 2017
VERACYTE, INC.
(Exact name of registrant as specified in its charter)
DELAWARE | 001-36156 | 20-5455398 | ||
(State or other jurisdiction of incorporation) | Commission File Number | (IRS Employer Identification No.) | ||
6000 Shoreline Court, Suite 300, South San Francisco, California | 94080 | |
(Address of principal executive offices) | (Zip Code) | |
Registrant’s telephone number, including area code: (650) 243-6300
N/A
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: | |
o | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
o | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
o | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
o | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934. |
Emerging growth company x |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. x |
Item 5.07 Submission of Matters to a Vote of Security Holders.
The following actions were taken at the Annual Meeting of Stockholders of Veracyte, Inc., held on June 6, 2017:
1. | The following Class I Directors were elected to serve until the 2020 Annual Meeting of Stockholders or until their successors are duly elected and qualified: |
For | Withheld | Broker Non-Votes | ||||||
Bonnie H. Anderson | 29,748,620 | 487,396 | 1,974,587 | |||||
Robert S. Epstein | 28,366,435 | 1,869,581 | 1,974,587 | |||||
Evan Jones | 23,034,675 | 7,201,341 | 1,974,587 | |||||
2. | The ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for 2017 was approved: |
For | Against | Abstain | |||||
32,207,194 | 3,404 | 5 | |||||
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated: June 6, 2017 | ||
VERACYTE, INC. | ||
By: | /s/ Keith S. Kennedy | |
Name: | Keith S. Kennedy | |
Title: | Chief Financial Officer | |
(Principal Financial and Accounting Officer) | ||